Notices for publication in the OJ nº T-337/18 of Tribunal General de la Unión Europea, October 19, 2018

• Resolution Date: October 19, 2018
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-337/18

Order of the President of the General Court of 24 August 2018 -Laboratoire Pareva and Biotech3D v Commission

(Case T-337/18 R and T-347/18 R)

(Interim relief - Regulation (EU) No 528/2012 - Biocidal products - Active substance PHMB (1415; 4.7) - Approval refused - Application for interim measures - Prima facie case - Weighing up of competing interests)

Language of the case: English

Parties

Applicant in case T-337/18 R: Laboratoire Pareva (Saint-Martin-de-Crau, France) (represented by: K. Van Maldegem and S. Englebert, lawyers)

Applicants in case T-347/18 R: Laboratoire Pareva (Saint-Martin-de-Crau, France) and Biotech3D Ltd & Co. KG (Gampern, Austria) (represented by: K. Van Maldegem and S. Englebert, lawyers)

Defendant: European Commission (represented by: R. Lindenthal and K. Mifsud-Bonnici, acting as Agents)

Re:

Application pursuant to Articles 278 and 279 TFEU seeking suspension of operation of Commission Implementing Decision (EU) 2018/619 of 20 April 2018 not approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 1, 5 and 6 (OJ 2018 L 102, p. 21)...